Molecular Docking Study of Substituted Benzamide Derivatives as Analgesic Candidates

Authors

DOI:

https://doi.org/10.33084/bjop.v8i3.8715

Keywords:

Benzamide, Drug Design, Inflammatory, Synthesis, Urea

Abstract

Thiourea derivatives represent a diverse class of compounds exhibiting a range of pharmacological activities, including antitubercular, analgesic, antiviral, and anticancer effects. Of particular interest is N-allyl-N'-(benzoylcarbamothioyl)benzamide, which is hypothesized to possess analgesic properties. A comprehensive in silico molecular docking study was undertaken to evaluate this potential. In silico assays, leveraging computer simulations, are invaluable tools for predicting outcomes, generating hypotheses, and accelerating drug discovery. Molecular docking, a prominent in silico application, facilitates structure-based screening by computationally assessing the binding affinity of compounds to target proteins. This research specifically aimed to predict the analgesic activity of N-allyl-N'-(benzoylcarbamothioyl)benzamide derivatives. To achieve this, various substituents, including methyl, methoxy, tert-butyl, dimethylamino, and halogens, were strategically incorporated at the ortho, meta, and para positions of the benzoylcarbamothioyl ring, generating a library of novel analgesic drug candidates. Compound activity was primarily evaluated using the rerank score. Additionally, ProTox-3.0 and pkCSM were utilized to predict these synthesized compounds' toxicity and physicochemical properties. Initial findings were encouraging, with 18 derivatives of N-allyl-N'-(benzoylcarbamothioyl)benzamide demonstrating enhanced predicted analgesic activity. Among these, six compounds exhibited promising analgesic properties without predicted toxicity. In conclusion, these in silico results suggest that certain N-allyl-N'-(benzoylcarbamothioyl)benzamide derivatives hold significant promise as potential analgesic agents, warranting further validation through subsequent laboratory and in vivo investigations.

Downloads

Download data is not yet available.

Author Biographies

  • Rahmawati Rahmawati, Indonesian Muslim University of Makassar

    Laboratory of Pharmaceutical Chemistry, Universitas Muslim Indonesia, Makassar, South Sulawesi, Indonesia

  • Rais Razak, Indonesian Muslim University of Makassar

    Laboratory of Pharmaceutical Chemistry, Universitas Muslim Indonesia, Makassar, South Sulawesi, Indonesia

  • Muammar Fawwaz, Indonesian Muslim University of Makassar

    Laboratory of Pharmaceutical Chemistry, Universitas Muslim Indonesia, Makassar, South Sulawesi, Indonesia

References

Gunaydin C, Bilge SS. Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level. Eurasian J Med. 2018;50(2):116-21. DOI: 10.5152/eurasianjmed.2018.0010; PMCID: PMC6039135; PMID: 30002579

van Rensburg R, Reuter H. An overview of analgesics: NSAIDs, paracetamol, and topical analgesics Part 1. S Afr Fam Pract. 2019;61(sup1):S4-S10. DOI: 10.1080/20786190.2019.1610228

Sharma S, Sharma SC. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems. Indian J Exp Biol. 1997;35(10):1025-31. PMID: 9475035

Dvorakova M, Langhansova L, Temml V, Pavicic A, Vanek T, Landa P. Synthesis, Inhibitory Activity, and In Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core. ACS Med Chem Lett. 2021;12(4):610-6. DOI: 10.1021/acsmedchemlett.1c00004; PMCID: PMC8040043; PMID: 33854702

Rouzer CA, Marnett LJ. Cyclooxygenases: structural and functional insights. J Lipid Res. 2009;50 Suppl(Suppl):S29-S34. DOI: 10.1194/jlr.r800042-jlr200; PMCID: PMC2674713; PMID: 18952571

Rouzer CA, Marnett LJ. Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs. Chem Rev. 2020;120(15):7592-641. DOI: 10.1021/acs.chemrev.0c00215; PMCID: PMC8253488; PMID; 32609495

Ölmez NA, Waseer F. New Potential Biologically Active Compounds: Synthesis and Characterization of Urea and Thiourea Derivativpes Bearing 1,2,4-oxadiazole Ring. Curr Org Synth. 2020;17(7):525-34. DOI: 10.2174/1570179417666200417112106; PMID: 32303172

Çelen A, Kaymakçıoğlu B, Gümrü S, Toklu H, Arıcıoğlu F. Synthesis and anticonvulsant activity of substituted thiourea derivatives. Marmara Pharm J. 2011;15(2):43-7. DOI: 10.12991/mpj.60092

Hardjono S, Siswandono S, Andayani R. Evaluation of N-benzoylthiourea derivatives as possible analgesic agents by predicting their physicochemical and pharmacokinetic properties, toxicity, and analgesic activity. Indones J Biotechnol. 2017;22(2):76-85. DOI: 10.22146/ijbiotech.27171

Razak R, Siswandono S, Ekowati J. Synthesis and Activity Test of 1-Allyl-3-(4-tertiary-Butylbenzoyl) Thioureaas a Candidate of an Analgesic Drug. J Farmasi Ilmu Kefarmasian Indones. 2022;9(1):17-23. DOI: 10.20473/jfiki.v9i12022.17-23

Fawwaz M, Purwono B, Sidiq Y, Arwansyah, Arsul MI, Fitriana, et al. Anti-inflammatory, Antioxidant, and Antibacterial Activities with Molecular Docking Studies of Vitex Trifolia L. Targeting Human COX-2 and Peroxiredoxin-5. ChemistrySelect. 2024;9(39):e202403834. DOI: 10.1002/slct.202403834

Budiati T, Suzana, Surdijati S. Sintesis, uji aktivitas analgesik dan anti-inflamasi senyawa benzoiltiourea Tersubstitusi. Majalah Farmasi Indones. 2010;21(1):68-76.

Meng XY, Zhang HX, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011;7(2):146-57. DOI: 10.2174/157340911795677602; PMCID: PMC3151162; PMID: 21534921

Salmaso V, Moro S. Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview. Front Pharmacol. 2018;9:923. DOI: 10.3389/fphar.2018.00923; PMCID: PMC6113859; PMID: 30186166

Kocyigit-Kaymakcioglu B, Celen AO, Tabanca N, Ali A, Khan SI, Khan IA, et al. Synthesis and biological activity of substituted urea and thiourea derivatives containing 1,2,4-triazole moieties. Molecules. 2013;18(3):3562-76. DOI: 10.3390/molecules18033562; PMCID: PMC6270039; PMID: 23519199

Ronchetti R, Moroni G, Carotti A, Gioiello A, Camaioni E. Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis. RSC Med Chem. 2021;12(7):1046-64. DOI: 10.1039/d1md00058f; PMCID: PMC8293013; PMID: 34355177

Fawwaz M, Mishiro K, Nishii R, Sawazaki I, Shiba K, Kinuya S, et al. Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR). Molecules. 2020;25(12):2914. DOI: 10.3390/molecules25122914; PMCID: PMC7356761; PMID: 32599930

Fawwaz M, Mishiro K, Nishii R, Makino A, Kiyono Y, Shiba K, et al. A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma. Pharmaceuticals. 2021;14(3):256. DOI: 10.3390/ph14030256; PMCID: PMC7998589; PMID: 33809064

Rowlinson SW, Kiefer JR, Prusakiewicz JJ, Pawlitz JL, Kozak KR, Kalgutkar AS, et al. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem. 2003;278(46):45763-9. DOI: 10.1074/jbc.m305481200; PMID: 12925531

Hussain S, Guruvayoorappan C, Komal KP, Ennaganti S. Molecular docking analysis of doronine derivatives with human COX-2. Bioinformation. 2020;16(6):483-92. DOI: 10.6026/97320630016483; PMCID: PMC7452741; PMID: 32884214

Kufareva I, Abagyan R. Methods of protein structure comparison. Methods Mol Biol. 2012;857:231-57. DOI: 10.1007/978-1-61779-588-6_10; PMCID: PMC4321859; PMID: 22323224

Ramírez D, Caballero J. Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? Molecules. 2018;23(5):1038. DOI: 10.3390/molecules23051038; PMCID: PMC6102569; PMID: 29710787

Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, et al. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023;13(1):13398. DOI: 10.1038/s41598-023-40160-2; PMCID: PMC10435576; PMID: 37592012

Bitencourt-Ferreira G, de Azevedo WF, Jr. Molegro Virtual Docker for Docking. Methods Mol Biol. 2019;2053:149-67. DOI: 10.1007/978-1-4939-9752-7_10; PMID: 31452104

Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem. 2015;58(9):4066-72. DOI: 10.1021/acs.jmedchem.5b00104; PMCID: PMC4434528; PMID: 25860834

Erhirhie EO, Ihekwereme CP, Ilodigwe EE. Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance. Interdiscip Toxicol. 2018;11(1):5-12. DOI: 10.2478/intox-2018-0001; PMCID: PMC6117820; PMID: 30181707

Chang Y, Hawkins BA, Du JJ, Groundwater PW, Hibbs DE, Lai F. A Guide to In Silico Drug Design. Pharmaceutics. 2022;15(1):49. DOI: 10.3390/pharmaceutics15010049; PMCID: PMC9867171; PMID: 36678678

Hursthouse MB, Hughes DS, Geblich T, Threlfall TL. Describing hydrogen-bonded structures; topology graphs, nodal symbols and connectivity tables, exemplified by five polymorphs of each of sulfathiazole and sulfapyridine. Chem Cent J. 2015;9(1):1. DOI: 10.1186/s13065-014-0076-x; PMCID: PMC4309923; PMID: 25649693

Nivatya HK, Singh A, Kumar N, Sonam, Sharma L, Singh V, et al. Assessing molecular docking tools: understanding drug discovery and design. Futur J Pharm Sci. 2015;11:111. DOI: 10.1186/s43094-025-00862-y

Downloads

Published

08/30/2025

Issue

Section

Analytical Pharmacy-Medicinal Chemistry

Categories

How to Cite

1.
Rahmawati R, Razak R, Fawwaz M. Molecular Docking Study of Substituted Benzamide Derivatives as Analgesic Candidates. Borneo J Pharm [Internet]. 2025 Aug. 30 [cited 2026 Nov. 10];8(3):242-51. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/8715

Similar Articles

11-20 of 181

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)